Gene · 200576
Papers1,790
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,790
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PI(3,5)P2 controls the signaling activity of class I PI3K. | Sci Adv | 2026 | 42814813 | PubTator, text mining | PubMed |
| JAK3 regulates PIP5K expression, promotes PIP2 generation and Ca2+ driven platelet activation in arterial thrombosis. | Blood | 2026 | 42766692 | PubTator, text mining | PubMed |
| Novel mutations of PIKFYVE identified in 322 sporadic cataract patients. | Ophthalmic Genet | 2026 | 42717816 | PubTator, text mining | PubMed |
| Targeting PIKfyve: Chemical Biology and Drug Discovery Insights. | Chem Biol Drug Des | 2026 | 42681571 | PubTator, text mining | PubMed |
| Ion transport as a determinant of membrane fusion and fission. | Nat Struct Mol Biol | 2026 | 42618799 | PubTator, text mining | PubMed |
| Synthesis and evaluation of 3,5-disubstituted isothiazolo[4,5-b]pyridines, pyrazolo[4,3-b]pyridines and isothiazolo[3,4-b]pyrazines as inhibitors of PIKfyve. | Bioorg Chem | 2026 | 42570378 | PubTator, text mining | PubMed |
| Quantitative comparison of PI(3,5)P2 biosensors reveals SnxA is the most sensitive and unbiased. | Mol Biol Cell | 2026 | 42555823 | PubTator, text mining | PubMed |
| A stress-adaptive lipid kinase axis defines metabolic vulnerabilities in neuroendocrine prostate cancer. | Cancer Cell | 2026 | 42546705 | PubTator, text mining | PubMed |
| A Stress-Adaptive Lipid Kinase Axis Defines Metabolic Vulnerabilities in Neuroendocrine Prostate Cancer. | bioRxiv | 2026 | 42528528 | PubTator, text mining | PubMed |
| PI4K and PIPK families in breast cancer: subtype-specific oncogenic mechanisms and precision therapeutic strategies. | Mol Biol Rep | 2026 | 42455373 | PubTator, text mining | PubMed |
| Beyond autophagic flux: selective autophagy adaptors and cargo prioritization in cardiac disease. | Cardiol Plus | 2026 | 42369864 | PubTator, text mining | PubMed |
| PIKfyve-specific Pt(II)-based targeted drug conjugate in treatment of ovarian cancer through multi-mode actions. | J Inorg Biochem | 2026 | 42365687 | PubTator, text mining | PubMed |
| PIKfyve influences inter-organelle contacts with lysosomes to modulate the endoplasmic reticulum. | J Cell Biol | 2026 | 42360289 | PubTator, text mining | PubMed |
| In Silico Systems Biology Approach for Prioritization of Candidate Genes Linked to Lipid Metabolism in the Context of Cardiovascular Disease Susceptibility in a Serbian Cohort. | Curr Issues Mol Biol | 2026 | 42353617 | PubTator, text mining | PubMed |
| Septins regulate kinase-inhibitor induced micron-scale vacuolation. | Exp Cell Res | 2026 | 42276196 | PubTator, text mining | PubMed |
| A PI(3,5)P2/CHMP4B axis on lysosomes is essential for microautophagic degradation of STING. | Nat Commun | 2026 | 42203786 | PubTator, text mining | PubMed |
| Synthesis, structure-activity relationships, and SARS-CoV-2 antiviral activity of 3,5-disubstituted isothiazolo[4,3-b]pyridines as PIKfyve inhibitors. | Front Chem | 2026 | 42179838 | PubTator, text mining | PubMed |
| IITZ01 attenuates fructose aggravated ulcerative colitis via prevention of macrophage activation and decrease in cytokine release via inhibition of PIP5 kinase. | Int Immunopharmacol | 2026 | 42140165 | PubTator, text mining | PubMed |
| Endolysosomal trafficking regulator SH-BC-893 inhibits coronavirus entry in vitro and in vivo. | Sci Rep | 2026 | 42115643 | PubTator, text mining | PubMed |
| How endosomal PIKfyve inhibition prevents viral membrane fusion and entry. | Proc Natl Acad Sci U S A | 2026 | 42101989 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/200576/papers